Regional : Regional Support to Address the Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases

Sovereign Project | 54079-001

The knowledge and support technical assistance (TA) will help the developing member countries (DMCs) of the Asian Development Bank (ADB) respond to the ongoing COVID-19 disease (COVID-19) outbreak with the aim of mitigating long-term damage to economies and adverse effects on population health.

Project Details

Project Name Regional Support to Address the Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases
Project Number 54079-001
Country / Economy Regional
Project Status Active
Project Type / Modality of Assistance Technical Assistance
Source of Funding / Amount
TA 9950-REG: Regional Support to Address the Outbreak of Novel Coronavirus (2019-nCoV)
Technical Assistance Special Fund US$ 2.00 million
TA 9950-REG: Regional Support to Address the Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases
Technical Assistance Special Fund US$ 2.00 million
TA 9950-REG: Regional Support to Address the Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases
Technical Assistance Special Fund US$ 40.00 million
Republic of Korea e-Asia and Knowledge Partnership Fund US$ 2.00 million
People's Republic of China Poverty Reduction and Regional Cooperation Fund US$ 2.00 million
TA 9950-REG: Regional Support to Address the Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases
Ireland Trust Fund for Building Climate Change and Disaster Resilience in Small Island Developing States US$ 296,000.00
TA 9950-REG: Regional Support to Address the Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases
High Level Technology Fund US$ 300,000.00
Technical Assistance Special Fund US$ 20.00 million
TA 9950-REG: Regional Support to Address the Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases
People's Republic of China Poverty Reduction and Regional Cooperation Fund US$ 2.00 million
Regional Malaria and Other Communicable Disease Threats Trust Fund under the Health Financing Partnership Facility US$ 6.35 million
TA 9950-REG: Regional Support to Address the Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases
Japan Fund for Prosperous and Resilient Asia and the Pacific US$ 2.00 million
Republic of Korea e-Asia and Knowledge Partnership Fund US$ 720,000.00
Operational Priorities OP1: Addressing remaining poverty and reducing inequalities
OP2: Accelerating progress in gender equality
OP3: Tackling climate change, building climate and disaster resilience, and enhancing environmental sustainability
OP6: Strengthening governance and institutional capacity
OP7: Fostering regional cooperation and integration
Sector / Subsector

Health / Disease control of communicable disease

Gender Some gender elements
Description The knowledge and support technical assistance (TA) will help the developing member countries (DMCs) of the Asian Development Bank (ADB) respond to the ongoing COVID-19 disease (COVID-19) outbreak with the aim of mitigating long-term damage to economies and adverse effects on population health.
Project Rationale and Linkage to Country/Regional Strategy

The PRC and other countries in the region have taken immediate action to respond to the outbreak. Despite the quick action taken, there are several gaps in the overall response efforts, as identified by WHO and other development partners. These are: (i) inadequate resources to strengthen the range of services for outbreak response; (ii) Paucity of robust economic analysis and other evidence to support decision-making; and (iii) weak regional multisectoral coordination mechanisms.

The TA will incorporate lessons learned from; following (i) the implementation of the Regional Malaria and Other Communicable Disease Threats Trust Fund;5F (ii) TA on Regional Support to Address the Outbreak of SARS, and (iii) the Grant Assistance for Prevention and Control of Avian Influenza in Asia and the Pacific, the Greater Mekong Subregion's Strengthening Regional Health Cooperation TA and Health Security Project.6F A major lesson is that flexible implementation arrangements and focus on the actual needs of DMCs for communicable disease control (i.e., hospital equipment, training and communication programs), together with the multi-sector and cross-departmental collaboration in ADB and between ADB and partner organizations such as the WHO, all contributed to the success of above-mentioned projects. These projects also highlighted the importance to provide not only country level assistance but also to coordinate interventions at the regional level and the establishment of regional coordination mechanisms similar to the working group spearheading the implementation of the GMS Regional Health Cooperation Strategy.

Impact

Health outcomes in Asia and the Pacific improved (ADB Strategy 2030)a; Increased number of people benefiting from improved health services, education services, or social protection (OP1)b; and Increased number of regional public goods initiatives successfully reducing cross- border environmental or health risks, or providing regional access to education services (OP7)c

Project Outcome
Description of Outcome

DMCs' capacities to prevent and contain outbreaks of COVID-19 and other communicable diseases strengthened

Progress Toward Outcome Assistance has been extended to 49 DMCs since the TA's approval. Subsequent increases in TA amount will finance (i) health system assessments and country readiness plans to ensure the capacity of developing member countries (DMCs) to access, introduce, manage, and monitor safe and effective coronavirus disease (COVID-19) vaccines; (ii) assistance to ensure that DMCs have the capacity in place to deliver safe and effective COVID-19 vaccines efficiently; (iii) support for developing projects that will finance the procurement of COVID-19 vaccines and related strengthening of vaccine delivery systems, and (iv) increasing the number of DMCs that will set up mechanisms to prevent and contain COVID-19 and other communicable diseases.
Implementation Progress
Description of Project Outputs

Support to DMCs affected and potentially affected by COVID-19 and other communicable diseases provided

Economic and health system assessments on the potential effect of COVID-19 conducted

Regional multisectoral coordination mechanisms strengthened

Status of Implementation Progress (Outputs, Activities, and Issues)

Output 1. Procurement, Portfolio and Financial Management Department (PPFD) has arranged the contracting of Medtecs Cambodia and the IDA Foundation to supply $11.05 million worth of personal protective equipment (PPEs) to 13 DMCs. PPFD has also arranged a logistic contract not-to-exceed with Kuehne and Nagel for the delivery of the personal protective equipment. Medtecs has completed 91% of deliveries, while IDA Foundation has completed 59% of deliveries. A total of $18 million of support for 26 DMCs for the procurement and delivery of PPEs, testing kits, thermal scanners, ventilators and other goods is being implemented through the Administrative Arrangement and its three Supplemental Arrangements between ADB and the United Nations Children's Fund (UNICEF), with deliveries to DMCs ongoing. Regional departments have supported Armenia, Georgia, and Turkmenistan to procure about $1.37 million worth of diagnostic equipment and supplies.

Output 2. The TA supported the undertaking of a costbenefit analysis of the COVID-19 control options in the Philippines, and the preparation of guidance notes on interventions for COVID-19 response and strengthening of health security, and on reviving the economy and resuming travel and tourism. It also supported an updated brief on the economic impact of COVID-19.

Output 3. The TA engaged a risk communication firm to help India, Myanmar and the Philippines develop communication strategies; a capacity building firm to conduct online training for all DMCs; and a consulting firm to help the Government of India improve its COVID-19 response through support for the development of a pandemic road map, the use of digital technologies, and health system strengthening to detect and respond to future outbreaks. It also engaged individual consultants and resource persons to increase countries' capacity in key COVID-19 response areas, including laboratory management, border health, water and sanitation, pandemic preparedness and response planning, and digital health advisory services.

Output 4. The TA engaged a risk communication firm to help India, Myanmar and the Philippines develop communication strategies; a capacity building firm to conduct online training for all DMCs; and a consulting firm to help the Government of India improve its COVID-19 response through support for the development of a pandemic road map, the use of digital technologies, and health system strengthening to detect and respond to future outbreaks. It also engaged individual consultants and resource persons to increase countries' capacity in key COVID-19 response areas, including laboratory management, border health, water and sanitation, pandemic preparedness and response planning, and digital health advisory services.

Geographical Location Regional
Summary of Environmental and Social Aspects
Environmental Aspects
Involuntary Resettlement
Indigenous Peoples
Stakeholder Communication, Participation, and Consultation
During Project Design
During Project Implementation Continuous consultation and communication with various stakeholders is being done to determine the needs of DMCs and how to address these concerns efficiently.
Business Opportunities
Consulting Services

The TA will require a total of 1,134 person-months of service from individual international and national consultants. Consultants will be engaged through individual selection to provide 425 person-months of international consultant service and 709 person-months of national consultant service. ADB will engage the consultants and carry out procurement following the ADB Procurement Policy (2017, as amended from time to time) and its associated TA staff instructions. Consultants will be initially work from home, then as and when feasible, may be mobilized to field.

The TA will require a total of 1,725 person-months of service from sixteen consulting firms: a risk communication firm; a frontline health worker capacity building firm; a traveler's health policy advisory firm; a vaccine policy advisory firm; a health system strengthening firm; a pandemic response firm; three vaccine advisory firms; a vaccine knowledge, attitudes, and practices (KAP) surveys firm; an immunization information systems (IIS) firm; two health capacity building firms; a vaccine logistics management firm; a vaccine regulation firm; a feasibility study firm; and a vaccine communications firm. The firms will be engaged through the single source selection method. The risk communication firm will be engaged to provide 10 person-months of international consultant service and 15 person-months of national consultant service. The frontline health worker capacity building firm will be engaged to provide 23 person-months of international consultant service and 9 person-months of national consultant service. The traveler's health policy advisory firm will be engaged to provide 16 person-months of international consultant service. The COVID-19 vaccine policy advisory firm will be engaged to provide 45 person-months of international consultants and 30 person-months of national consultant service. The health system strengthening firm will be engaged to provide 150 person-months of national consultant service. The pandemic response firm will be engaged to provide 192 person-months of national consultant service. Each vaccine advisory firm will be engaged to provide 80 person-months of international consultant service and 90 person-months of national person-months consultant service. The KAP surveys firm will be engaged to provide 50 person-months of international consultant service and 50 person-months of national consultant service. The IIS firm will be engaged to provide 50 person-months of international consultant service and 50 person-months of national consultant service. Each health capacity building firm will be engaged to provide 30 person-months of international consultant service and 5 person-months of national person-months consultant service. The vaccine logistics management firm will be engaged to provide 120 person-months of international consultant service and 80 person-months of national consultant service. The vaccine regulation firm will be engaged to provide 60 person-months of international consultant service and 50 person-months of national consultant service. The feasibility study firm will be engaged to provide 40 person-months of international consultant service and 30 person-months of national consultant service. The vaccine communications firm will be engaged to provide 50 person-months of international consultant service and 25 person-months of national consultant service. ADB will engage the firms and carry out procurement following the ADB Procurement Policy (2017, as amended from time to time) and its associated TA staff instructions.

Procurement ADB will procure necessary medical supplies and reagents, medicines and vaccines, PPE for health care staffs, and digital health software and hardware needed for rapidly building up DMC capacities. The procurement and disbursement decision authorities and signatories in ADB is the Director-General of SDCC, in consultation with Procurement, Portfolio and Financial Management Department (PPFD). Procurement will follow the ADB Procurement Policy (2017, as amended from time to time) and its associated project administration instructions and/or staff instructions. The procurement of goods will be coordinated with other technical agencies (such as United Nations agencies) to avoid duplication of supply. Given the need for flexibility, ADB can also outsource the procurement to identified implementing government agencies in recipient DMCs and United Nations agencies which have stronger links to the supply market or provide funding to these agencies to procure and supply the goods in accordance with arrangements acceptable to ADB
Responsible ADB Officer Arora, Dinesh
Responsible ADB Department Sectors Group
Responsible ADB Division Human and Social Development Sector Office (SG-HSD)
Executing Agencies
Asian Development Bank
Timetable
Concept Clearance 14 Feb 2020
Fact Finding 06 Feb 2020 to 06 Feb 2020
MRM -
Approval 25 Feb 2020
Last Review Mission -
Last PDS Update 03 Dec 2020

TA 9950-REG

Milestones
Approval Signing Date Effectivity Date Closing
Original Revised Actual
25 Feb 2020 - 25 Feb 2020 28 Feb 2022 14 Feb 2025 -
Financing Plan/TA Utilization Cumulative Disbursements
ADB Cofinancing Counterpart Total Date Amount
Gov Beneficiaries Project Sponsor Others
64,000,000.00 15,663,518.72 0.00 0.00 0.00 0.00 79,663,518.72 06 Nov 2023 56,041,633.72

Project Data Sheets (PDS) contain summary information on the project or program. Because the PDS is a work in progress, some information may not be included in its initial version but will be added as it becomes available. Information about proposed projects is tentative and indicative.

The Access to Information Policy (AIP) recognizes that transparency and accountability are essential to development effectiveness. It establishes the disclosure requirements for documents and information ADB produces or requires to be produced.

The Accountability Mechanism provides a forum where people adversely affected by ADB-assisted projects can voice and seek solutions to their problems and report alleged noncompliance of ADB's operational policies and procedures.

In preparing any country program or strategy, financing any project, or by making any designation of, or reference to, a particular territory or geographic area in this document, the Asian Development Bank does not intend to make any judgments as to the legal or other status of any territory or area.


Safeguard Documents See also: Safeguards
Safeguard documents provided at the time of project/facility approval may also be found in the list of linked documents provided with the Report and Recommendation of the President.

None currently available.


Evaluation Documents See also: Independent Evaluation

None currently available.



The Access to Information Policy (AIP) establishes the disclosure requirements for documents and information ADB produces or requires to be produced in its operations to facilitate stakeholder participation in ADB's decision-making. For more information, refer to the Safeguard Policy Statement, Operations Manual F1, and Operations Manual L3.

Requests for information may also be directed to the InfoUnit.

Tenders

Tender Title Type Status Posting Date Deadline
Health Expert/Long Term International Consultant Individual - Consulting Closed
Senior Project Coordinator Individual - Consulting Closed
Climate and Health Expert/Long Term International Consultant Individual - Consulting Closed
Health Security Expert/Team Leader: Support to DMC's to Develop a Pandemic Fund Proposal Individual - Consulting Closed
Health Security Expert/Team Leader: Support to Indonesia to Develop a Pandemic Fund Proposal Individual - Consulting Closed
National Surveillance, Laboratory and Health Systems Expert: Support to Indonesia to Develop a Pandemic Proposal Individual - Consulting Closed
Health Security Expert: Support to Bangladesh to Develop a Pandemic Fund Proposal Individual - Consulting Closed
Surveillance, Laboratory and Health Systems Expert: Support to Bangladesh to Develop a Pandemic Fund Proposal Individual - Consulting Closed
Future Health: ADB's Health Systems (Accelerator) Course Firm - Consulting Closed
Training and Capacity Building for Vaccines, Therapeutics and Diagnostics Firm - Consulting Closed
Human Resource in Health – Public and Private Firm - Consulting Closed
Finance Expert Individual - Consulting Closed
INO: Health Finance Reform Manager Individual - Consulting Closed
INO: Health Actuary Expert Individual - Consulting Closed
Operationalization of Climate and Health Action Firm - Consulting Closed
LAO: AEFI compensation Legal Framework Expert Individual - Consulting Closed
Health System Resilience Specialist Individual - Consulting Closed
Human Resource in Health – Public and Private Expert Individual - Consulting Closed
Human Resource in Health – Public and Private - Expert 3 Individual - Consulting Closed
Human Resource in Health – Public and Private - Expert 1 Individual - Consulting Closed
Human Resource in Health – Public and Private - Expert 2 Individual - Consulting Closed
Senior Health Financing Expert Individual - Consulting Closed
Public Health Specialist Individual - Consulting Closed
THA Data Sharing and Web Application Development Expert Individual - Consulting Closed
THA: Mathematical modelling Expert Individual - Consulting Closed
THA Database Management and Data Architecture Design Expert Individual - Consulting Closed
THA Advance Data Analytics Expert Individual - Consulting Closed
Senior Activity and Protocol Officer Individual - Consulting Closed
Human Resource for Health (HRH) vision 2040 – India, Bangladesh and other LMICs Individual - Consulting Closed
Human Resource for Health (HRH) vision 2040 – India, Bangladesh and other LMICs Individual - Consulting Closed
Human Resource for Health (HRH) vision 2040 – India, Bangladesh and other LMICs Individual - Consulting Closed
Human Resource for Health (HRH) vision 2040 – India, Bangladesh and other LMICs Individual - Consulting Closed
Regional Support to Address the Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases Firm - Consulting Closed
Regional Support to Address the Outbreak of Coronavirus Disease 2019 and Potential Outbreaks of Other Communicable Diseases_Medical Education Firm - Consulting Closed
Health Expert (National) Individual - Consulting Closed
Health Security Expert Individual - Consulting Closed
One Health Expert Individual - Consulting Closed
LAO: Provincial Healthcare Waste Management Consultant 2 (Luang Prabang Based) Individual - Consulting Closed
LAO: Provincial Healthcare Waste Management Consultant 2 (Vientiane Capital Based) Individual - Consulting Closed
LAO: Provincial Healthcare Waste Management Consultant 2 (Champasak Based) Individual - Consulting Closed
THA: Adverse Event Following Immunization/ Adverse Drug Reaction Surveillance Expert Individual - Consulting Closed
LAO: Provincial Healthcare Waste Management Consultant 1 (Vientiane Capital Based) Individual - Consulting Closed
INO: Primary Care Program Analyst (Maternal, Newborn, Child Health and Stunting) Individual - Consulting Closed
THA: Data Scientist (Social Listening and Risk Perception Analysis) Individual - Consulting Closed
LAO: Communications Officer (Based in Xaisomboun Province) Individual - Consulting Closed
LAO: Provincial Healthcare Waste Management Consultant 1 (Champasak Based) Individual - Consulting Closed
LAO: Provincial Healthcare Waste Management Consultant 1 (Luang Prabang Based) Individual - Consulting Closed
THA: Pharmacovigilance Specialist Individual - Consulting Closed
LAO: National Healthcare Waste Management Individual - Consulting Closed
LAO: International Healthcare Waste Management Individual - Consulting Closed
THA: Data Presentation and Database Development Expert Individual - Consulting Closed
MON: Health Systems Expert Individual - Consulting Closed
Architecture and engineering expert for vaccines manufacturing (5) Individual - Consulting Closed
International Health Expert and Portfolio Specialist Individual - Consulting Closed
Vaccines strategy & manufacturing expert 2 Individual - Consulting Closed
Vaccines strategy & regulatory affairs expert (3) Individual - Consulting Closed
Vaccines strategy & manufacturing expert 1 Individual - Consulting Closed
Vaccines strategy & manufacturing expert 4 Individual - Consulting Closed
INO: Primary Care Program Analyst (COVID-19 Primary Health Care Transformation) Individual - Consulting Closed
LAO Senior Technical Coordinator Individual - Consulting Closed
LAO: National Procurement Expert Individual - Consulting Closed
INO: Data Analyst on Primary Health Care Individual - Consulting Closed
INO: Primary Care Program Analyst (COVID-19 Maternal and Child Health) Individual - Consulting Closed
Supporting the Strengthening of the National Centre for Disease Control (NCDC) Firm - Consulting Closed
Support to the Ministry of Health, Viet Nam for the Development of the Disease Prevention Law Firm - Consulting Closed
TA Implementation Coordinator A Individual - Consulting Closed
TA Implementation Coordinator B Individual - Consulting Closed
Long-term Sustainable Financing Assessment for COVID-19 and Adult Vaccination Firm - Consulting Closed
Landscape Assessment and Capacity Development related to Use of mRNA and DNA-based Biopharmaceutical Technology to Increase Health Security Firm - Consulting Closed
INO: Health Technology Program Specialist Individual - Consulting Closed
INO: Partnership Specialist Individual - Consulting Closed
INO: Health Specialist 2 (Pharmaceutical Industry Specialist) Individual - Consulting Closed
INO: Health Communication Specialist  Individual - Consulting Closed
INO: Program Analyst on Health System Resilience Individual - Consulting Closed
INO: Health Talent Transformation Specialist Individual - Consulting Closed
INO: Public Health Specialist for COVID-19 Testing 2 Individual - Consulting Closed
INO: Primary Care Program Analyst (COVID-19 Disease Prevention) Individual - Consulting Closed
INO: Data Analyst on Public Health Policy Individual - Consulting Closed
VIE: Planning and Laboratory Specialist Individual - Consulting Closed
VIE: Finance Specialist Individual - Consulting Closed
VIE: Procurement Specialist Individual - Consulting Closed
INO: Health Data System Specialist Individual - Consulting Closed
LAO: National M&E and Data Officer - COVID-19 Vaccine Deployment Individual - Consulting Closed
PHI: Vaccine Supply Chain and Logistics Planning Expert Individual - Consulting Closed
PHI: Local Level Logistics and Inventory Analyst Individual - Consulting Closed
PHI: Local Level Logistics and Supply Planning Specialist for Visayas and Mindanao Individual - Consulting Closed
PHI: Local Level Logistics and Supply Planning Specialist for Luzon Individual - Consulting Closed
Vaccine Knowledge, Attitudes, and Practices (KAP) Surveys Firm Firm - Consulting Closed
LAO: Planning and Coordination Officer 2 – COVID 19 Vaccine Deployment (Oudomxay-Based) Individual - Consulting Closed
LAO: Planning and Coordination Officer 4 – COVID 19 Vaccine Deployment (Vientiane-Based) Individual - Consulting Closed
LAO: National Cold Chain Equipment and Logistics Officer COVID-19 Vaccine Deployment Individual - Consulting Closed
LAO: AEFI and Risk Communications Expert (International) Individual - Consulting Closed
LAO: Planning and Coordinator Officer 1 – COVID 19 Vaccine Deployment (Vientiane Based) Individual - Consulting Closed
LAO: Planning and Coordination Officer 3– COVID 19 Vaccine Deployment (Khuammuan-Based) Individual - Consulting Closed
LAO: Cold Chain Equipment and Logistics Officer-COVID-19 Vaccine Deployment (International) Individual - Consulting Closed
PHI: Senior Vaccine Product Logistics Expert Individual - Consulting Closed
INO: Health Specialist 3 (Finance Reform Management) Individual - Consulting Closed
INO: Business Intelligence Analyst Individual - Consulting Closed
INO: Project Management Specialist (re-advertised) Individual - Consulting Closed
LAO: AEFI and Risk Communications Officer - COVID-19 Vaccine Deployment (National) Individual - Consulting Closed
Immunization Information Systems Firm Firm - Consulting Closed
Vaccine Logistics Management Firm Firm - Consulting Closed
INO: Health System Analyst Individual - Consulting Closed
INO: Project Management Specialist Individual - Consulting Closed
INO: Health Specialist 1 (International Relations Specialist) Individual - Consulting Closed
INO: Health System Product Development Specialist Individual - Consulting Closed
INO: Health Sector Institutional Development Specialist Individual - Consulting Closed
INO: Health Specialist 2 (Pharmaceutical Industry Specialist) Individual - Consulting Closed
INO: Health Financing Specialist Individual - Consulting Closed
INO: Health Sector Talent Management Specialist Individual - Consulting Closed
Vaccine Advisory Firm for Central West Asia Firm - Consulting Closed
SARD: Digital Health Expert Individual - Consulting Closed
SDSC-HEA: Health Systems and Policy Specialist Individual - Consulting Closed
IND: Health Systems Strengthening Firm Firm - Consulting Closed
TA Implementation Coordinator (International) Individual - Consulting Closed
INO: Collaboration Affairs Specialist Individual - Consulting Closed
INO: Data Specialist 1 (re-advertised) Individual - Consulting Closed
International Health Expert for Bangladesh Individual - Consulting Closed
Laos National Border Specialist Individual - Consulting Closed
INO: COVID-19 Vaccination Specialist Individual - Consulting Closed
INO: Data Specialist 2 Individual - Consulting Closed
INO: Hospital Administration Specialist 1 Individual - Consulting Closed
INO: Strategic Delivery Unit Coordinator Individual - Consulting Closed
INO-Public Health Specialists for COVID-19 Contact Tracing Individual - Consulting Closed
INO: Public Health Specialist for COVID-19 Testing 1 Individual - Consulting Closed
INO: Hospital Administration Specialist 2 Individual - Consulting Closed
INO: Public Health Specialist for COVID-19 Testing 2 Individual - Consulting Closed
MYA: Health Planning Expert Individual - Consulting Closed
PAK: National Research Associate (Junior Epidemiologist) Individual - Consulting Closed
MYA: Health Planning Expert Individual - Consulting Closed
MYA: Public Financial Management Specialist Individual - Consulting Closed
MON: National Immunization Specialist Individual - Consulting Closed
CWRD: Biomedical Engineer Individual - Consulting Closed
PAK: National Tech and Innovation Advisor Individual - Consulting Closed
Senior Project Coordinator B Individual - Consulting Closed
Project Analyst A Individual - Consulting Closed
TA Activity Coordinator Individual - Consulting Closed
Project Analyst B Individual - Consulting Closed
PHI: Vaccine Expert Individual - Consulting Closed
Senior Project Coordinator A Individual - Consulting Closed
SERD: GMS: Health Security Knowledge Management Expert Individual - Consulting Closed
PAK: COVID-19 Modeling Support Individual - Consulting Closed
SERD: GMS Health Security Knowledge Management Expert Individual - Consulting Closed
PAK: Senior Supply Chain and COVID-LMIS Support Individual - Consulting Closed
PAK: Management Coordinator Individual - Consulting Closed
PAK: Junior Supply Chain and COVID-LMIS Support Individual - Consulting Closed
PAK: COVID GIS Mapping and LMIS Technical Assistant Individual - Consulting Closed
PHI: Public Health Expert Individual - Consulting Closed
SERD/LAO: National Border Health Specialist Individual - Consulting Closed
SERD/CAM: National Border Health Specialist Individual - Consulting Closed
KAZ: Public Health Expert Individual - Consulting Closed
PAK:COVID-19 Logistics Management Information Consultant (1 of 4) Individual - Consulting Closed
PAK:COVID-19 Logistics Management Information Consultant (1 of 4) Individual - Consulting Closed
PAK: COVID-19 Logistics Management Information Consultant (1 of 4) Individual - Consulting Closed
PAK:COVID-19 Logistics Management Information Consultant (1 of 4) (54079-001) Individual - Consulting Closed
AFG: Health Security and Health Systems Strengthening Expert Individual - Consulting Closed
PAK: Public Health Management and Monitoring Expert Individual - Consulting Closed
TAJ: Public Health Expert Individual - Consulting Closed
Epidemiologist Individual - Consulting Closed
SDSC-HEA: Health Security and Health Systems Expert (1 of 2) [COVID-19] Individual - Consulting Closed
SERD-GMS: International Procurement Individual - Consulting Closed
SERD-PHI: National Risk Communications Consultant Individual - Consulting Closed
EARD-MON: Medical Procurement Specialist Individual - Consulting Closed
TA 9950 - National Procurement Expert Individual - Consulting Closed
Project Coordinator (National Consultant) Individual - Consulting Closed
Senior Health Security and Health Systems Specialist Individual - Consulting Closed

Contracts Awarded

Contract Title Approval Number Contract Date Contractor | Address Executing Agency Total Contract Amount (US$) Contract Amount Financed by ADB (US$)
Capacity Development Technical Assistance Technical Assistance 9950 10 Jul 2023 IQVIA Consulting and Information Services India Private Limited (INDIA) | Unit No. 1031, 10th Floor, Hindustan times Building, K.G Marg, Connaught Place, New Delhi 110001, India Asian Development Bank 475,456.00
Capacity Development Technical Assistance Technical Assistance 9950 04 May 2023 Chinese Center for Disease Control and Prevention (P.R.C.) | 27 Nanwei Road, Xicheng District, Beijing 100050 China Asian Development Bank 249,993.00
Capacity Development Technical Assistance Technical Assistance 9950 03 Feb 2023 Duke-NUS Graduate Medical School Singapore (SINGAPORE) | Centre of Regulatory Excellence, Level 5 8 College Road, 169857 Singapore Asian Development Bank 929,565.00
Capacity Development Technical Assistance Technical Assistance 9950 20 Dec 2022 Accenture International Limited (IRELAND) | Grand Canal Square, Grand Canal Harbour, Dublin 2, Ireland Asian Development Bank 323,310.00
Capacity Development Technical Assistance Technical Assistance 9950 01 Dec 2022 McKinsey & Co. (PHILIPPINES) | 7F Zuellig Building, Paseo de Roxas corner Makati Avenue, MAKATI CITY 1226 PHILIPPINES Asian Development Bank 577,280.00
Capacity Development Technical Assistance Technical Assistance 9950 09 Nov 2022 IQVIA Consulting and Information Services India Private Limited (INDIA) in association with Primus Partners Pvt. Ltd. (INDIA) | Unit no 1031, 10th Floor, Hindustan times Building, K.G Marg, Connaught Place, New Delhi, India 110001 Asian Development Bank 989,999.00
Capacity Development Technical Assistance Technical Assistance 9950 18 Oct 2022 Center for Community Health and Injury Prevention (VIET NAM) | Room 302, House A4, Hang Chao street, Cat Linh ward, Dong Da district Hanoi, 11510 Viet Nam Asian Development Bank 674,234.00
Capacity Development Technical Assistance Technical Assistance 9950 25 Aug 2022 Curatio International Foundation (GEORGIA) | 3, Kavsadze str., Tbilisi, 0179 Georgia Asian Development Bank 172,571.00
Capacity Development Technical Assistance Technical Assistance 9950 13 Apr 2022 THE AUSTRALIAN NATIONAL UNIVERSITY (AUSTRALIA) | College of Asia and the Pacific, Coombs Building #09 ACTON, ACT 0200 Australia Asian Development Bank 475,000.00
Capacity Development Technical Assistance Technical Assistance 9950 12 Oct 2021 Johns Hopkins University (U.S.A.) | 615 North Wolfe St., Baltimore City, Maryland 21205 United States Asian Development Bank 1,649,906.00
CDTA Technical Assistance 9950 23 Aug 2021 CROWN AGENTS LIMITED | ST. NICHOLAS HOUSE, ST. NICHOLAS ROAD SUTTON, SURREY SM1 1EL UNITED KINGDOM, or Blue Fin Building London United Kingdom Asian Development Bank 983,700.00
Capacity Development Technical Assistance 9950 22 Feb 2021 PATH(UNITED STATES) | 2201 Westlake Avenue, Suite 200 Seattle, WA 98121 United States Asian Development Bank 947,847.00
Capacity Development Technical Assistance 9950 12 Oct 2020 MCCANN-ERICKSON USA,INC.D/B/A MCCANN GLOBAL HEALTH(UNITED STATES) | 622 Third Avenue, New York, New York 10017 United States Asian Development Bank 203,230.00
Capacity Development Technical Assistance 9950 20 Aug 2020 KPMG Advisory Services Private Limited(INDIA) | Lodha Excelus,Apollo Mills Cmpd,NM Joshi xmi,Mumbai 400011/Kamala Mills Compound, Senapati Bapat Marg, Lower Parel Mumbai Asian Development Bank 992,345.00